Qube Research & Technologies (QRT)’s Caribou Biosciences CRBU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$336K	Sell	176,697 -27,955	-14%	-$48K	﹤0.01%	2846
2025 Q4	$325K	Buy	204,652 +159,502	+353%	+$335K	﹤0.01%	2926
2025 Q3	$105K	Buy	+45,150	New	+$85.2K	﹤0.01%	3054
2024 Q3	–	Sell	-220,017	Closed	-$361K	–	3435
2024 Q2	$361K	Buy	+220,017	New	+$703K	﹤0.01%	2244
2023 Q3	–	Sell	-83,612	Closed	-$355K	–	4120
2023 Q2	$355K	Buy	+83,612	New	+$376K	﹤0.01%	1616
2023 Q1	–	Sell	-24,025	Closed	-$151K	–	2601
2022 Q4	$151K	Buy	+24,025	New	+$214K	﹤0.01%	1895
2022 Q3	–	Sell	-14,326	Closed	-$78K	–	2568
2022 Q2	$78K	Sell	14,326 -35,932	-71%	-$275K	﹤0.01%	2020
2022 Q1	$461K	Buy	+50,258	New	+$530K	﹤0.01%	1571

Other funds holding CRBU

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRBU Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Caribou Biosciences (CRBU) stake by 14% in Q1 2026, selling an estimated $48K and leaving 176,697 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Qube Research & Technologies (QRT) first reported a position in CRBU in Q1 2022 and has held it in 8 quarters since. The position peaked at $461K in Q1 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

Qube Research & Technologies (QRT) held 176,697 shares of Caribou Biosciences worth $336K as of Q1 2026.
Qube Research & Technologies (QRT) sold 27,955 Caribou Biosciences shares in Q1 2026, an estimated $48K.
Caribou Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2846 holding.
Qube Research & Technologies (QRT) first reported a position in Caribou Biosciences in Q1 2022 and has held it in 8 quarters since.
Qube Research & Technologies (QRT)'s Caribou Biosciences position peaked at $461K in Q1 2022.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.